Volume 230, Issue 1

Search all Psychopharmacology articles

November 2013

15 articles in this issue

Mind the mortality gap: the importance of metabolic function in mental illnesses
Oliver D. Howes
Katherine Beck
Commentary 05 September 2013 Pages: 1 - 2
A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients
Shaohua Hu
Mingrong Yao
Yi Xu
Original Investigation 05 April 2013 Pages: 3 - 13
The lack of association between components of metabolic syndrome and treatment resistance in depression
Marina Sagud
Alma Mihaljevic-Peles
Nela Pivac
Original Investigation 12 April 2013 Pages: 15 - 21
The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients
Avi Amrami-Weizman
Rachel Maayan
Michael Poyurovsky
Original Investigation 05 July 2013 Pages: 23 - 27
Serotonin depletion counteracts sex differences in anxiety-related behaviour in rat
Jakob Näslund
Erik Studer
Elias Eriksson
Original Investigation 17 May 2013 Pages: 29 - 35
The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder
Yankelevitch-Yahav Roni
Joel Daphna
Original Investigation 18 May 2013 Pages: 37 - 48
Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive–compulsive symptoms
Jun Cai
Wen Zhang
Chen Zhang
Original Investigation 10 May 2013 Pages: 49 - 55
Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brain
Glenn T. Konopaske
Nicolas R. Bolo
Joseph T. Coyle
Original Investigation 10 May 2013 Pages: 57 - 67
The association between the catechol-O-methyltransferase Val108/158Met polymorphism and hyperactive–impulsive and inattentive symptoms in youth
Matea Nikolac Perkovic
Evelyn Kiive
Nela Pivac
Original Investigation 29 May 2013 Pages: 69 - 76
Determination of reliable reference genes for multi-generational gene expression analysis on C. elegans exposed to abused drug nicotine
Faten A. Taki
Baohong Zhang
Original Investigation 17 May 2013 Pages: 77 - 88
Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task
A. Bari
T. W. Robbins
Original Investigation Open access 17 May 2013 Pages: 89 - 111
Insights into functional pharmacology of α₁ GABA_A receptors: how much does partial activation at the benzodiazepine site matter?
Srđan Joksimović
Zdravko Varagic
Miroslav M. Savić
Original Investigation 18 May 2013 Pages: 113 - 123
Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders
Ines Peraile
Noelia Granado
Esther O’Shea
Original Investigation 17 May 2013 Pages: 125 - 135
The effects of amphetamine sensitization on conditioned inhibition during a Pavlovian–instrumental transfer task in rats
Michael W. Shiflett
Meaghan Riccie
RoseMarie DiMatteo
Original Investigation 29 May 2013 Pages: 137 - 147
Erratum to: Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics
J. Martínez-Clemente
R. López-Arnau
E. Escubedo
Erratum 17 September 2013 Pages: 149 - 149

Volume 230, Issue 1

Mind the mortality gap: the importance of metabolic function in mental illnesses

A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients

The lack of association between components of metabolic syndrome and treatment resistance in depression

The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients

Serotonin depletion counteracts sex differences in anxiety-related behaviour in rat

The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder

Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive–compulsive symptoms

Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brain

The association between the catechol-O-methyltransferase Val108/158Met polymorphism and hyperactive–impulsive and inattentive symptoms in youth

Determination of reliable reference genes for multi-generational gene expression analysis on C. elegans exposed to abused drug nicotine

Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task

Insights into functional pharmacology of α₁ GABA_A receptors: how much does partial activation at the benzodiazepine site matter?

Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders

The effects of amphetamine sensitization on conditioned inhibition during a Pavlovian–instrumental transfer task in rats

Erratum to: Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics

Navigation